WEREWOLF THERAPEUTICS INC Share Price Today: Live Updates & Key Insights
WEREWOLF THERAPEUTICS INC share price today is $0.4182, up 18.55%. The stock opened at $0.3776 against the previous close of $0.3602, with an intraday high of $0.436 and low of $0.3675.
WEREWOLF THERAPEUTICS INC Share Price Chart
WEREWOLF THERAPEUTICS INC
WEREWOLF THERAPEUTICS INC Share Price Performance
WEREWOLF THERAPEUTICS INC Institutional Holdings
WEREWOLF THERAPEUTICS INC Market Status
WEREWOLF THERAPEUTICS INC Fundamentals
Market Cap 17.50 M
PB Ratio 1.4732
PE Ratio 0.0
Enterprise Value 8.95 M
Total Assets 69.40 M
Volume 2988462
WEREWOLF THERAPEUTICS INC Company Financials
About WEREWOLF THERAPEUTICS INC & investment objective
Company Information Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. In addition, it develops WTX-1011, a conditionally activated INDUCER T cell engager molecule that targets STEAP 1 for prostate cancer, as well as WTX-2022 that targets CDH6 for ovarian and kidney cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
Organisation Biotechnology
Employees 14
Industry Biotechnology
CEO Dr. Daniel J. Hicklin Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
WEREWOLF THERAPEUTICS INC FAQs
What is the share price of WEREWOLF THERAPEUTICS INC today?
The current share price of WEREWOLF THERAPEUTICS INC is $0.4182.
Can I buy WEREWOLF THERAPEUTICS INC shares in India?
Yes, Indian investors can buy WEREWOLF THERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy WEREWOLF THERAPEUTICS INC shares in India?
You can easily invest in WEREWOLF THERAPEUTICS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy WEREWOLF THERAPEUTICS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of WEREWOLF THERAPEUTICS INC.
Can I buy fractional shares of WEREWOLF THERAPEUTICS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of WEREWOLF THERAPEUTICS INC?
WEREWOLF THERAPEUTICS INC has a market cap of $17.50 M.
In which sector does WEREWOLF THERAPEUTICS INC belong?
WEREWOLF THERAPEUTICS INC operates in the Biotechnology sector.
What documents are required to invest in WEREWOLF THERAPEUTICS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of WEREWOLF THERAPEUTICS INC?
The PE ratio of WEREWOLF THERAPEUTICS INC is N/A and the PB ratio is 1.47.